Vaksin Covid-19 Oxford–AstraZeneca: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan
Tag: Suntingan visualeditor-wikitext
NFarras (bicara | kontrib)
Tidak ada ringkasan suntingan
Baris 40:
| synonyms = Covishield<small> ([[India]])</small><ref>{{cite news |title=Already produced 40-50 million dosages of Covishield vaccine, says Serum Institute |url=https://www.thehindu.com/business/Industry/already-produced-40-50-million-dosages-of-covishield-vaccine-says-serum-institute/article33438655.ece |work=The Hindu |date=28 December 2020 |language=en-IN}}</ref>
}}
{{COVID-19 pandemic sidebar|expanded=medis}}
 
'''AZD1222''', juga dikenal sebagai '''ChAdOx1 nCoV-19''', adalah sebuah [[vaksin COVID-19]] yang dikembangkan oleh [[Universitas Oxford]] dan [[AstraZeneca]] yang diberikan lewat [[suntikan intraotot]].<ref>{{cite news |last1=Walsh |first1=Nick |last2=Shelley |first2=Jo |last3=Duwe |first3=Eduardo |last4=Bonnett |first4=William | name-list-style = vanc |date=27 July 2020 |title=The world's hopes for a coronavirus vaccine may run in these health care workers' veins |url=https://edition.cnn.com/2020/07/27/americas/brazil-covid-19-sinovac-vaccine-intl/index.html |work=[[CNN]] |location=[[São Paulo]] |access-date=3 August 2020 |archive-date=3 August 2020 |archive-url= https://web.archive.org/web/20200803211040/https://edition.cnn.com/2020/07/27/americas/brazil-covid-19-sinovac-vaccine-intl/index.html |url-status=live }}</ref><ref name="NCT04400838">{{cite web |title=Investigating a Vaccine Against COVID-19 |url=https://clinicaltrials.gov/ct2/show/NCT04400838 |website=[[ClinicalTrials.gov]] |publisher=[[United States National Library of Medicine]] |type=Registry |id=NCT04400838 |date=26 May 2020 |access-date=14 July 2020 |archive-date=11 October 2020 |archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/ |url-status=live }}</ref><ref name="EudraCT-2020-001228-32">{{cite web |url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB |title=A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 |website=EU Clinical Trials Register |publisher=European Union |type=Registry |id=[[EudraCT]] 2020-001228-32 |date=21 April 2020 |access-date=3 August 2020 |archive-date=5 October 2020 |archive-url=https://web.archive.org/web/20201005201654/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB |url-status=live }}</ref><ref name="ISRCTN89951424">{{cite journal |title=A Phase III study to investigate a vaccine against COVID-19 |website=ISRCTN |type=Registry |id=ISRCTN89951424 |doi=10.1186/ISRCTN89951424 |date=26 May 2020 | vauthors = O'Reilly P | doi-access=free }}</ref>